Sulfadiazine crystalluria in a patient with lupus nephritis

Autor: Maria Jesús Ruiz Álvarez, Sergio Molina Blas, Marta Barrionuevo González, M. Eugenia Peñas Lorite, José Manuel Gasalla Herraiz
Rok vydání: 2022
Předmět:
Zdroj: Advances in Laboratory Medicine / Avances en Medicina de Laboratorio. 3:210-211
ISSN: 2628-491X
DOI: 10.1515/almed-2022-0046
Popis: Objectives It is estimated that 29% of patients treated with sulfadiazine ultimately develop acute kidney failure. Diagnosis is based on urine sediment analysis. Case presentation A 71-year-old woman with loss of visual acuity in the context of a flare of systemic erythematosus lupus (SEL). A diagnosis of acute retinal necrosis was established, pending etiological confirmation. Empirical treatment with sulfadiazine was initiated. Follow-up analyses included urine sediment, which revealed pH 6, 30–50 RBCs/field, urothelial cells and lower tract epithelial cells, hyaline casts, fatty casts or Maltese cross, and abundant sulfadiazine crystals. The finding was reported to the Unit of Nephrology, and treatment was immediately suspended. Conclusions Sulfadiazine is an antibiotic of the family of sulfamides. Crystalization of sulfadiazine in the renal tubules may cause acute interstitial nephritis. These crystals adopt different shapes according to the metabolite that crystalizes: unaltered forms precipitate into dense, globular crystals, whereas in other cases, as in the case reported in this paper, crystals adopt a fan-shaped, shocks-of-wheat morphology.
Databáze: OpenAIRE